Germany is on the verge of launching its national lung cancer screening program for at-risk patients – and MeVis is contributing its many years of experience!
Visit us from May 28–30, 2025, at the 106th German Radiology Congress (ROEKO) and discover how Veolity the comprehensive software solution for lung cancer screening, supports you efficiently, safely, and with a forward-looking approach.
MeVis Medical Solutions, with over 10 years of experience in national and international lung cancer screening programs and pilot projects - including in the USA, Hong Kong, Canada, Australia, the UK, France, and Norway - is a globally recognized software partner. This expertise is now being channeled into the rollout of lung screening in Germany with a unified solution in "Made in Germany" quality, tailored specifically to the requirements of the local healthcare system.
Veolity combines state-of-the-art technology in a single platform and already meets all legal requirements:
In addition to the radiology reporting software Veolity, MeVis offers a comprehensive solution for the introduction of screening programs, supporting you in all aspects of lung cancer screening - including patient management (partner application) and incidental findings.
Meet us in person and explore our complete solution for German lung cancer screening at ROEKO 2025. Let our experience and ideas inspire you in conversation.
Visit MeVis at ROEKO 2025 in Wiesbaden at booth no. 50 Süd. We look forward to connecting with you!
RheinMain CongressCenter
Friedrich-Ebert-Allee 1
65185 Wiesbaden
Germany